BROADWOOD CAPITAL INC Long-Term Concentrated

CIK: 0001278387 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 15, 2019

Total Value ($000): $816,583 (100.0% shares, 0.0% debt)

Holdings (7)

STAA STAAR SURGICAL CO 45.0%

Value ($000) $367,222 Shares 10,740,630 Est. Cost $8.21 Unrealized +330.9%

MNST MONSTER BEVERAGE CORP NEW 31.3%

Value ($000) $255,397 Shares 4,679,308 Est. Cost $22.71 Unrealized +25.5%

IWM ISHARES TR 7.9%

Value ($000) $64,298 Shares 420,000 Est. Cost $109.78 Unrealized —

— BIOTIME INC 5.4%

Value ($000) $44,185 Shares 33,728,991 Est. Cost $3.14 Unrealized —

AXON AXON ENTERPRISE INC 5.1%

Value ($000) $41,355 Shares 760,062 Est. Cost $27.50 Unrealized +86.4%

— ONCOCYTE CORPORATION 3.9%

Value ($000) $31,988 Shares 8,098,267 Est. Cost $3.91 Unrealized —

— AGEX THERAPEUTICS INC 1.5%

Value ($000) $12,138 Shares 2,997,156 Est. Cost $2.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
STAA	STAAR SURGICAL CO	10,740,630	$367,222	45.0%	$8.21	+330.9%	COM PAR $0.01	852312305
MNST	MONSTER BEVERAGE CORP NEW	4,679,308	$255,397	31.3%	$22.71	+25.5%	COM	61174X109
IWM	ISHARES TR	420,000	$64,298	7.9%	$109.78	—	RUSSELL 2000 ETF	464287655
—	BIOTIME INC	33,728,991	$44,185	5.4%	$3.14	—	COM	09066L105
AXON	AXON ENTERPRISE INC	760,062	$41,355	5.1%	$27.50	+86.4%	COM	05464C101
—	ONCOCYTE CORPORATION	8,098,267	$31,988	3.9%	$3.91	—	COM	68235C107
—	AGEX THERAPEUTICS INC	2,997,156	$12,138	1.5%	$2.99	—	COM	00848H108